Bloomberg Law
Aug. 6, 2021, 7:24 PM

Teva ‘Skinny Label’ Ruling Comes Amid Lawmaker Drug Cost Fight

Ian Lopez
Ian Lopez
Senior Reporter

Republican and Democratic lawmakers trying to push down prescription drug prices may have just had a wrench thrown into their efforts thanks to a federal appellate court, following a decision legal experts say will make it more complicated for generics to enter the marketplace.

Brand-name drug manufacturers often take out patents on new uses for old medications. Generic drugmakers trying to enter the marketplace often slap “skinny labels” on their copycat versions of the drugs that carve out the name brand’s new, patented uses to prevent courts from holding them liable for infringement.

But on Thursday, the U.S. Court of ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.